| Literature DB >> 27618035 |
Suzana Saric1, Raja K Sivamani2.
Abstract
Polyphenols are antioxidant molecules found in many foods such as green tea, chocolate, grape seeds, and wine. Polyphenols have antioxidant, anti-inflammatory, and antineoplastic properties. Growing evidence suggests that polyphenols may be used for the prevention of sunburns as polyphenols decrease the damaging effects of ultraviolet A (UVA) and ultraviolet B (UVB) radiation on the skin. This review was conducted to examine the evidence for use of topically and orally ingested polyphenols in prevention of sunburns. The PubMed database was searched for studies that examined polyphenols and its effects on sunburns. Of the 27 studies found, 15 met the inclusion criteria. Seven studies were conducted on human subjects and eight on animals (mice and rats). Eleven studies evaluated the effects of topical polyphenols, two studies examined ingested polyphenols, and two studies examined both topical and ingested polyphenols. Polyphenol sources included the following plant origins: green tea, white tea, cocoa, Romanian propolis (RP), Calluna vulgaris (Cv), grape seeds, honeybush, and Lepidium meyenii (maca). Eight studies examined green tea. Overall, based on the studies, there is evidence that polyphenols in both oral and topical form may provide protection from UV damage and sunburn, and thus are beneficial to skin health. However, current studies are limited and further research is necessary to evaluate the efficacy, mechanism of action, and potential side effects of various forms and concentrations of polyphenols.Entities:
Keywords: UVA; UVB; antioxidant; flavonoids; polyphenols; skin damage; sunburns
Mesh:
Substances:
Year: 2016 PMID: 27618035 PMCID: PMC5037798 DOI: 10.3390/ijms17091521
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 5.923
Figure 1Chemical structure of (−)-epigallocatechin-3-gallate (EGCG).
Polyphenol studies summary.
| Polyphenol Source | Test Subjects, Country | Polyphenol Administration | Polyphenol Content | Dosage | Study Design, Duration | Control or Placebo | Major Outcome Measures | Major Results | Reference |
|---|---|---|---|---|---|---|---|---|---|
| Chocolate | Humans (women), | Systemic (ingested chocolate) | HFC: Epicatechins (mg/day) 10.50 ± 7.54; | 30 g of chocolate consumed daily over 12 weeks | 2-group, parallel, double-blind, randomized controlled trial | LFC group | Minimal erythema dose (MED) (represents skin sensitivity to UVR) | No significant protective effect of HFC vs. LFC consumption on skin sensitivity to UVR | Mogollon et al., 2014 [ |
| Catechins (mg/day) 11.94 ± 7.91 | Treatment groups: | ||||||||
| LFC: Epicatechins (mg/day) 10.65 ± 7.00; | |||||||||
| G2: Low flavonol chocolate (LFC), 30 g/day for 12 + 3 weeks wash-out period ( | |||||||||
| Red wine | Healthy male physicians | Topical and systemic | Wine A: 1606 mg/L | Topical: | Interventional 4-arm study | Ethanol 12% (topical part of the study only) | MED baseline (MED prior to local and systemic wine exposure) | Topical wine application: no significant difference between MED baseline and MED local | Moehrle et al., 2009 [ |
| Spring 2002 | |||||||||
| Wine B: 2052 mg/L | Treatment groups: | ||||||||
| MED local (MED before and after application of topical ethanol or wine) | Oral consumption of wine: Wine A: no significant difference between MED baseline and MED systemic ( | ||||||||
| Systemic: | |||||||||
| Wine C: 2100 mg/L | |||||||||
| Green tea | Humans, | Topical | Green tea catechins (30%–40%) + other polyphenols (total polyphenol content 40%–50%) | Topical applied to skin | Split body controlled study | Positive control: Placebo lotion (no green tea extract) on the other buttock + UVB | Amount of sunburn cells found on skin biopsies one day after UVB exposure (days 6 and 34) in skin pre-treated with OM24 vs. placebo | Day 6: number of sunburn (apoptotic) cells was unchanged with OM24-pretreatment vs. placebo treated groups | Mnich et al., 2009 [ |
| 34 days duration | |||||||||
| Treatment groups: | Day 34: number of sunburn cells reduced by 38.9% with OM24-pretreatment ( | ||||||||
| Data of | (OM24 topical: contained green tea extract) | ||||||||
| 3 times daily for 34 days | |||||||||
| Negative control: placebo lotion, no UVB | |||||||||
| OM24: 4% green tea extract | |||||||||
| Green tea | Humans, 18–50 years old | Topical | 1% to 10% green tea polyphenol (GTP); | 0.2 mL GTP; concentration 1%–10% | Interventional multi-arm study with each subject as their own control. | Control topical | UV-induced erythema: examined clinically via erythema index at 24, 48 and 72 h post UVR | 2.5% GTP: significant reduction in amount of sunburn cells at 24, 48 and 72 h after UVR ( | Elmets et al., 2001 [ |
| Number of sunburn cells found in skin biopsies after UVR | Green tea application pre-UV exposure: inhibited erythema formation ( | ||||||||
| Treatment groups: | |||||||||
| DNA damage in skin samples post UVR | |||||||||
| 5% GTP: highest chemoprotective properties compared to EGCG, ECG, EGC, EC | |||||||||
| polyphenol constituents = 95% pure, from Japan | |||||||||
| G2: skin sites on subjects’ back treated with equal concentrations of EGCG, ECG, EC, EGC and 5% GTP ( | |||||||||
| Determine which purified polyphenol constituent was responsible for chemoprotective properties | |||||||||
| Topical GTP application led to reduction in | |||||||||
| Sunburn cells (68% reduction, | |||||||||
| Biopsies obtained | |||||||||
| DNA damage (55% reduction, | |||||||||
| Green tea | Humans, 18–65 years old, | Systemic | Green tea catechins (GTC) 1080 mg/day | 3 GTC capsules (180 mg GTC each) + 2 vitamin C capsules (50 mg each) twice daily (stabilizes GTC in gut lumen) | Double-blind randomized placebo-controlled trial | Placebo capsules (maltodextrin) | Difference in MED (defined as sunburn threshold; lowest dose producing visually detectable erythema) at 12 weeks compared to baseline | G1 vs. G2: No significant difference in MED between the GTC group and placebo group ( | Farrar et al., 2015 [ |
| Treatment groups: | |||||||||
| Within group analysis: | |||||||||
| G2: placebo (maltodextrin capsules identical to GTC and Vitamin C capsules) | |||||||||
| Upper buttock skin irradiated with UVR (5% UVB, 95% UVA) at baseline and 12 weeks post-supplementation with GTC; 24 h post-UVR, skin visually examined for erythema | |||||||||
| Green tea (GT) and White tea (WT) | Humans, Age not reported, | Topical | GT and WT | 2.5 mg/cm2 | Randomized, double-blind controlled trial | G1: No UV, no treatment | Mean % of CD1a cells (Langerhans cells (LC)) per epidermis unit area in each treatment group – detected via anti-CD1a immunostaining | LC results: | Camouse et al., 2009 [ |
| Treatment groups: | |||||||||
| G2: UV only, no treatment | G4 ( | ||||||||
| G3: vehicle + UV | |||||||||
| G4: WT + UV | |||||||||
| G5: GT + UV | |||||||||
| DNA damage – detected via anti-8-hydroxy-2′-deoxyguanosine (OHdG) staining | |||||||||
| Topical applied (2.5 mg/cm2) to buttock, dried for 15 min, UVR applied at 2 × MED, topical applied again; 72 h later biopsies from 5 sites obtained | |||||||||
| G4 22% reduction and G5 35% reduction in CD1a staining compared to G1 | |||||||||
| No difference between G4 and G5 in protection against LC depletion ( | |||||||||
| DNA damage results: | |||||||||
| G4 and G5: 8-OHdG level not significantly different from G1 ( | |||||||||
| G4 ( | |||||||||
| G4 and G5: no difference in level of protection against UV 8-OHdG formation | |||||||||
| Green tea | Humans, | Topical | 2%, 3%, 4% and 5% GTE | Applied to 5 sites on dorsal skin 30 min before and 6, 24, 48 h after UVR | Interventional 7-arm study with each subject serving as their own control. | Site 1: no UVR (negative control) | Erythema at various sites assessed via photographs | Erythema: | Li et al., 2009 [ |
| MED determined 2 weeks before trial:dorsal skin sites exposed to UVR for 4 days: | Thickness of stratum corneum (TSC) and epidermis (TE) (measured by microscopy) | ||||||||
| Site 5: least amount of erythema | |||||||||
| Site 1: no UVR | |||||||||
| Site 2: UVR only (1.5 MED) | |||||||||
| Site 3: vehicle cream + UVR | Level of cytokeratins (CK): CK 5/6 and CK 16 and metalloproteinases (MMP): MMP-2 and MMP-9 (assessed semi-quantitatively: | ||||||||
| Site 4: 2% GTE + UVR | |||||||||
| Site 5: 3% GTE + UVR | |||||||||
| Site 6: 4% GTE + UVR | |||||||||
| Day 7: | |||||||||
| Site 7: 5% GTE + UVR | |||||||||
| Score 0 = negative | |||||||||
| Score 1 = slightly positive | |||||||||
| Site 3 to 7: topicals applied 30 min before UVR and 6, 24, 48 h after last UVR; 7 biopsies obtained 72 h after UVR | Score 2 = moderately positive | ||||||||
| TSC and TE: | |||||||||
| Site 3: TSC increased by 36% and TE by 42% | |||||||||
| Compared to site 2, only site 4 and 5 topicals prevented TE increase ( | |||||||||
| Score 3 = strongly positive | |||||||||
| Compared to site 1, site 2, 3, 6, 7 had increased TSC ( | |||||||||
| CK 5/6 and CK16: | |||||||||
| Site 4, 5, 6, 7: significant protection from UVR, especially site 5 | |||||||||
| Density of CD1a Langerhans cells (LC) in epidermis and dermis (determined via immunohistochemistry and reported as LCs/mm2) | |||||||||
| MMP-2 and MMP-9: | |||||||||
| Site 1: slight to moderate expression of both | |||||||||
| Site 2, 3, 7: highest overexpression of moth | |||||||||
| LC depletion: | |||||||||
| Compared to site 1, mean density of LC decreased in site 2 (75%), 3 (64%), 6 (65%), 7 (71%) | |||||||||
| Site 5 (46% depletion) | |||||||||
| The difference between site 1 and all others was significant ( | |||||||||
| Romanian Propolis (RP) | Female Swiss mice, | Topical | RP1 = 3 mg polyphenols/cm2 | Topical treatment 3 times over 24 h | Interventional 3-arm study | 2 control groups: | Amount of sunburn cell formation in epidermis 24 h after UVB exposure as seen on biopsy samples | Pre-treatment with RP extracts: minimized amount of sunburn cells (1.68-fold less for RP1 and 1.77-fold for RP2; | Bolfa et al., 2013 [ |
| 3 experiential subsets; 3 groups of treated animals in each | |||||||||
| Treatment groups: | |||||||||
| G1: mice treated with vehicle topical | |||||||||
| G2: mice treated with RP1 topical | |||||||||
| G3: mice treated with RP2 topical | |||||||||
| RP post-UVB-treatment: significantly reduced amount of sunburn cell (2.04-fold less for RP1 and 1.98-fold for RP2; | |||||||||
| Subset 1 ( | |||||||||
| Subset 2 ( | |||||||||
| (sunburn cells identified based on cell membrane shrinkage and nuclear condensation) | |||||||||
| RP2 = 1.5 mg polyphenols/cm2 | Subset 3 ( | ||||||||
| Number of sunburn cells was significantly reduced with RP as compared to the UVB + vehicle group ( | |||||||||
| Skin biopsies obtained 24 h after UVB exposure | |||||||||
| SKH-1 Hairless Mice, | Topical | 4 mg polyphenols/cm2 | Apply to skin 30 min before each UVB exposure for 10 days | Interventional 5-arm study | No treatment | Amount of sunburn cell formation after UVB exposure (quantified via histopathological examination of skin biopsies showing apoptosis: pyknotic nuclei and condensed cytoplasm) | UVB (G3) increased number of sunburn cells (3.2 ± 0.76) compared with control (G1) (0.07 ± 0.15; | Olteanu et al., 2012 [ | |
| Romania | |||||||||
| Treatment groups | Pre-treatment with Cv extract significantly reduced the number of sunburn cells compared to groups treated with UVB (G4, 1.80 ± 0.45 vs. G3, 3.2 ± 0.76; | ||||||||
| G1: control (no treatment) | |||||||||
| G2: vehicle (hydrogel containing Cv extract) | |||||||||
| G3: UVB only | |||||||||
| G4: Cv + UVB | |||||||||
| G5: Cv + vehicle + UVB | |||||||||
| Extract was applied topically on skin 30 min before each UVB exposure for 10 days; skin fragments excised 24 h after the end of experiment | |||||||||
| Grape seeds - | SKH-1 mice, | Topical | BM 2.5 mg polyphenols (PF)/cm2 | Different doses applied before UVB or 30 min after UVB | Interventional 8-arm study | No treatment G1: Control, G2: vehicle, G3: UV-B only G4: vehicle + UV-B | Number of sunburn cells in skin samples after UVB (identification of apoptotic cells: small, dense nuclei due to nuclear condensation and eosinophilic cytoplasm) | G1, G2: only a few cells underwent normal cell death, with random distribution (0.07% ± 0.15% and 0.74% ± 0.51%) | Filip et al., 2011 [ |
| Treatment groups: | |||||||||
| G1: Control | |||||||||
| G3, G4: UVR increased number of sunburn cells significantly (2.26% ± 1.15%; | |||||||||
| G2: vehicle | |||||||||
| G3: UV-B only | |||||||||
| G5: BM 2.5 mg PF/cm2 pretreatment reduced number of sunburn cells (1.34% ± 1.17%; 41% inhibition) | |||||||||
| G4: vehicle + UV-B | |||||||||
| G5: BM 2.5 mg polyphenols (PF)/cm2 + UV-B | |||||||||
| G6: BM 4 mg PF/cm2 + UV-B | |||||||||
| G6: pretreatment effect on sunburn cells not reported | |||||||||
| G7: UV-B + BM 2.5 mg PF/cm2 | |||||||||
| G8: UV-B + BM 4 mg PF/cm2 | G7, G8: Both doses of BM extract applied after UV-B reduced sunburn cells (1.21 ± 0.29; 47% inhibition with BM 2.5 mg PF/cm2 and 1.07 ± 0.32; 53% inhibition with BM 4 mg PF/cm2 | ||||||||
| BM 4 mg PF/cm2 | |||||||||
| Extract applied to skin, 30 min later = UVB exposure; total 10 days. | |||||||||
| G7 and G8 had UVB exposure and then BM application 30 min later. | |||||||||
| 24 h after last experiment, skin excised for histopathological analysis. | |||||||||
| Honeybush extracts, hesperidin and mangiferin | SKH-1 female mice, | Topical | See results | Topical applied to the skin of SKH-1 mice before daily exposures to UVB light for 10 days | Interventional 4-arm study | Positive, negative and vehicle control groups | Total polyphenol content (determined using Folin Ciocalteu’s phenol reagent) | Fermented honeybush extract: significantly ( | Petrova et al., 2011 [ |
| Treatment groups: G1: ‘‘green’’ honeybush | |||||||||
| G2: fermented honeybush | Concentration of hesperidin and mangiferin in honeybush extract (determined by high-performance liquid chromatography) | ||||||||
| G3: hesperidin treatment | |||||||||
| G4: mangiferin treatment | |||||||||
| Hesperidin and mangiferin: concentrations significantly ( | |||||||||
| Each topical was applied to skin, 30 min later skin was exposed to UVB; 10 consecutive days; skin was excised 24 h after last treatment | |||||||||
| ‘‘Green’’ and fermented Honeybush extracts markedly reduced sunburn effects of UVB, while pure compounds hesperidin and mangiferin did not | |||||||||
| EGCG | Mice (wild type) and IL-12 knockout mice, | Topical | EGCG | 1 mg/cm2 skin | Interventional case-control study. | No UVB and no EGCG ( | Tumor growth after UVB exposure (skin examined visually for growth of tumors and papillomas); growth >1 mm and if persisted for 2 weeks was recorded | Sunburn cells were maximum 10 h after UVB exposure and decreased thereafter | Meeran et al., 2006 [ |
| Duration: 35 weeks | |||||||||
| Treatment groups: | EGCG pre-treatment: | ||||||||
| Detection of apoptotic sunburn cells on skin biopsy samples after H&E stain using light microscopy (sunburn cell: cell membrane shrinkage and nuclear condensation) | |||||||||
| Topical applied 25–30 min before UVB exposure for total of 10 days; 1 week after last UVB mice got UVB exposure 3 times per week for total 35 weeks; tumor growth evaluated and skin samples obtained | |||||||||
| -inhibits growth of UVB-induced tumors in WT mice ( | |||||||||
| Green tea | Mice (female CD-1, SKH-1 mice and A/J mice), | Topical and Systemic | Topical: EGCG 49.5% | Topical: 3.6 mg green tea applied twice weekly | Interventional case-control study | Water | % mice with skin tumors | Topical GTP: decreased number of tumors by 94% | Conney et al., 1992 [ |
| 25 weeks duration | Oral GTP (1.25% and 2.50%) inhibited sunburn formation ( | ||||||||
| Treatment groups: | |||||||||
| Topical experiment: | |||||||||
| Oral: 1.25% GT extract and 2.5% GT extract (both were 100% green tea concentration) | |||||||||
| 5–8 weeks old, | |||||||||
| Skin tumors >1 mm diameter | Oral GTP: decreased number of skin tumors per mouse at 15 weeks (0.3 ± 0.1, | ||||||||
| G1: DMBA + TPA ( | |||||||||
| G2: DMBA + TPA + GTP ( | Subjective measurement of skin lesions based on redness measured daily | ||||||||
| 0 = no lesion | |||||||||
| 1 = barely detectable red lesion | |||||||||
| 2 = moderate red lesion | |||||||||
| 3 = bright red lesion | |||||||||
| Mice were initiated with 200 mmol DMBA and promoted with 5 mmol TPA twice weekly for 20 weeks; G2 got GTP twice weekly; skin tumor formation assessed after treatment with TPA | |||||||||
| Oral experiment 1 | |||||||||
| G1: 1.25% green tea + UVB ( | |||||||||
| G2: 2.50% green tea + UVB ( | |||||||||
| Two weeks of green tea, then UVB exposure for 7 days while continuing green tea | |||||||||
| Oral experiment 2: | |||||||||
| Mice consumed green tea extract 1.25% for 2 weeks then exposed to UVB for 10 days. Mice continued GT intake during UVB period and 1 week after. Then, mice only given water and treated topically with TPA. | |||||||||
| Rats, | Topical | Boiled and freeze-dried extract total polyphenols: 1.36 ± 0.001 g/100 g | 0.05 mg of extract | Interventional 5-arm study with four different treatment groups. | no radiation, no treatment (non-irradiated control) | Epidermal thickness assessed by measuring epidermal height on skin biopsy samples | Aqueous extract of maca resulted in significantly lower epithelial height than pulverized maca ( | Gonzales-Castaneda et al., 2008 [ | |
| 3 weeks | |||||||||
| Animal backs were shaved in 5 areas 24 h before UVR exposure; they spent 15 min in front of respective UVR once/week for 3 weeks. (see treatments below). 2 h after last UVR, skin biopsies obtained | |||||||||
| Treatment groups: | |||||||||
| G1 ( | |||||||||
| T1: aqueous heated extract of maca | |||||||||
| Non-boiled aqueous extract polyphenol 0.78 ± 0.001 g/100 g | |||||||||
| Aqueous boiled extract vs. non-boiled pulverized extract in preventing skin damage (quantified by epithelial thickness) | |||||||||
| T2: non-boiled pulverized extract of maca | |||||||||
| T3: sunscreen SPF 30 | |||||||||
| T4: distilled water (vehicle) | |||||||||
| T5: UVC only (irradiated control) | |||||||||
| Aqueous extract of maca prevents UV-induced skin damage (UVA, UVB, UVC all | |||||||||
| G2 ( | |||||||||
| G3 ( | |||||||||
| G4 ( | |||||||||
| Green tea | Rats, | Topical | 2% EGCG | 2% EGCG topical applied 30 min before or after UVA exposure | Interventional 3-arm study | No topical, no UV radiation | Amount of sunburn cells caused by UVA radiation pre and post EGCG topical application (sunburn cells identified by pyknotic nucleus and eosinophilic cytoplasm in biopsy sample) | Group pretreated with EGCG prior to UVA exposure had a statistically significant decrease in sunburnt cells at 24 hours compared with UVA exposure only group (0.67 0.52) | Sevin et al., 2007 [ |
| Group treated with EGCG after UVA exposure had no difference in the development of sunburnt cells compared to the UVA exposure only group. | |||||||||
| Rats’ backs were shaved and 24 h later rats were placed 30 cm from UVA light. G2 and G3 received 200 mg topical on their back (see below). Biopsies obtained 24 and 72 h after UVA exposure. Histological examination of sunburn cells performed. | |||||||||
| Treatment groups: | |||||||||
| G1: UVA exposure | |||||||||
| G2: UVA exposure + post-treatment EGCG | |||||||||
| G3: pre-treatment with EGCG + UVA exposure | |||||||||
Abbreviations: A/J: A/J mouse strain; BM: Burgund mare; CD-1: CD-1 mouse strain; CK: cytokeratin; Cv: Calluna vulgaris; DMBA: 7,12-dimethylbenz[α]anthracene; EC: epicatechin; ECG: epicatechin gallate; EGC: epigallocatechin; EGCG: epigallocatechin gallate; G1: group 1; G2: group 2; G3: group 3; G4: groups 4; G5: group 5; G6: group 6; G7: group 7; G8: group 8; GT: green tea; GTP: green tea polyphenol; GTC: green tea catechin; HFC: high flavonol chocolate; IL-12: interlukin-12; LC: Langerhans cell; LFC: low flavonol chocolate; MED: minimal erythema dose; MMP: metalloproteinase; OHdG: anti-8-hydroxy-2′-deoxyguanosine; OM24: green tea extract treatment lotion; PIH: post-inflammatory hyperpigmentation; RP: Romanian propolis; RP1: Romanian propolis 1; RP2: Romanian propolis 2; SKH-1: SKH-1 mouse strain; T1: treatment 1; T2: treatment 2; T3: treatment 3; T4: treatment 4; T5: treatment 5; TE: thickness of epidermis; TPA: 12-O-tetradecanoylphorbol-13-acetate; TSC: thickness of stratum corneum; UV: ultraviolet; UVA: ultraviolet A; UVB: ultraviolet B; UVC: ultraviolet C; UVR: ultraviolet radiation; WT: white tea.